Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PRO214 polypeptides

PRO214 polypeptides

US Patent 7619062 · Granted Nov 17, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Methods of qualitatively and/or quantitatively analyzing properties of activatab2025
Methods for treating cancer and the use of biomarkers as a predictor of clinical2025
Method to use gene expression to determine likelihood of clinical outcome of ren2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
BET inhibitors as a treatment for myelofibrosis2025
Methods of treating cancer by targeting cold tumors2025
Method of using an anti-epidermal growth factor receptor (EGFR) activatable anti2024
Methods of treating prostate cancer2024
Compositions and methods for conjugating activatable antibodies2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Method to use gene expression to determine likelihood of clinical outcome of ren2023